Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

13.750
-0.100-0.72%
Volume:1.33M
Turnover:18.35M
Market Cap:35.70B
PE:22.20
High:13.980
Open:13.850
Low:13.660
Close:13.850
52wk High:15.080
52wk Low:7.457
Shares:2.60B
HK Float Shares:2.60B
Volume Ratio:0.79
T/O Rate:0.05%
Dividend:0.21
Dividend Rate:1.50%
EPS(LYR):0.619
ROE:16.31%
ROA:6.75%
PB:3.31
PE(LYR):22.20
PS:4.03

Loading ...

Assessing Simcere Pharmaceutical Group (SEHK:2096) Valuation After Strong 2025 Earnings Report

Simply Wall St.
·
Apr 08

SIMCERE PHARMA Keeps Share Base Steady in March 2026; Public Float Above 15.45% Threshold

Bulletin Express
·
Apr 02

Bocom International Raises SIMCERE PHARMA (02096) Target Price to HK$17.7, Keeps "Buy" Rating

Stock News
·
Mar 30

Assessing Simcere Pharmaceutical Group’s Valuation After Strong Earnings And Positive SIM0237 Cancer Trial Results

Simply Wall St.
·
Mar 30

Simcere Pharmaceutical Group Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Simply Wall St.
·
Mar 29

Stock Track | SIMCERE PHARMA Soars 7.87% in Morning Session on New CEO Appointment and Strong Financial Results

Stock Track
·
Mar 27

SIMCERE PHARMA Shares Surge Nearly 8% in Morning Session Following Appointment of Former HENGRUI PHARMA Chairman as CEO

Stock News
·
Mar 27

Simcere Pharmaceutical FY2026 RSU awards climb to 2.2 million; HKD 11.18 closing price holds on grant date

Reuters
·
Mar 26

SIMCERE PHARMA Invests HK$22.03 Million in Share Buyback

Stock News
·
Mar 26

Simcere Pharma Buys Back 1.97 Million Shares, Brings Cumulative Repurchases to 12.83 Million

Bulletin Express
·
Mar 26

Simcere Pharmaceutical Group (SEHK:2096) Margin Rebound Challenges Long Term Earnings Skepticism

Simply Wall St.
·
Mar 26

BRIEF-Simcere Pharmaceutical Says Unit To Buy Entire Stake In Target Company For RMB30.8 Million

Reuters
·
Mar 25

SIMCERE PHARMA Subsidiary to Acquire Full Ownership of Shanghai Simcere Diagnostics Technology for RMB 30.76 Million, Aims to Establish Open Innovation Hub

Stock News
·
Mar 25

SIMCERE PHARMA Reports Record Revenue of 7.73 Billion Yuan for 2025, with Innovative Drug Sales Rising

Stock News
·
Mar 25

SIMCERE PHARMA Announces Appointment of Co-Company Secretary

Stock News
·
Mar 25

SIMCERE PHARMA Announces Dr. Zhou Yunshu as New CEO

Stock News
·
Mar 25

Simcere Pharma names industry veteran Zhou Yunshu as Chief Executive Officer; Chairman Ren Jinsheng steps down from CEO role

Bulletin Express
·
Mar 25

Simcere Pharma Plans Article Overhaul to Support Virtual AGMs and Treasury-Share Regime

Bulletin Express
·
Mar 25

SIMCERE PHARMA appoints Cherie Mak as Joint Company Secretary following Wai Ling Wong’s resignation

Bulletin Express
·
Mar 25

Simcere Pharma Announces RMB0.18 Final Dividend for FY2025

Bulletin Express
·
Mar 25